Leidos (LDOS) director discloses dividend-equivalent stock on Form 4
Rhea-AI Filing Summary
Leidos Holdings, Inc. director Robert S. Shapard reported a small change in his ownership of company stock. On 12/31/2025, he acquired 3.7915 shares of common stock at a price of $0, described as dividend equivalent rights credited under a Key Executive Stock Deferral Plan. Following this transaction, he indirectly holds 1,620.4763 shares through the deferral plan, 2,500 shares through a family limited partnership, and directly owns 57,078.08 shares of Leidos common stock. This filing reflects routine equity-based compensation rather than an open‑market stock purchase or sale.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 3.7915 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- F1. Dividend equivalent rights.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Leidos (LDOS) report in this Form 4?
The Form 4 reports that director Robert S. Shapard acquired 3.7915 shares of Leidos common stock on 12/31/2025 at a price of $0, recorded as dividend equivalent rights.
Is this Leidos (LDOS) insider transaction a purchase on the open market?
No. The Form 4 shows the shares were acquired at $0 as dividend equivalent rights under a Key Executive Stock Deferral Plan, not through an open‑market trade.
What is the reporting person’s relationship to Leidos (LDOS)?
The reporting person, Robert S. Shapard, is listed as a Director of Leidos Holdings, Inc. and filed the Form 4 as a single reporting person.